It has been suggested that PIK3CA mutation may have prognostic value in predicting survival outcome in breast cancer patients3 – partly because PIK3CA mutations tend to be associated with hormone receptor-positive tumours that are responsive to hormone therapies4. Here, PIK3CA is linked to breast carcinoma.